Main menu


You are here

Home › Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study › Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study

Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study

Primary tabs

Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study

Tue, 2023-10-03 10:44 — mike kraft

 

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems seb_ra / iStock CIDRAP

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...

 

 

Country / Region Tags: 
Canada
General Topic Tags: 
COVID-19
Symptoms
Treatments
Data
Demographics
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.440 seconds.